VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
AstraZeneca PLC vs Lifco AB (publ)
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisLifco AB (publ)
LIFCO-B · Nasdaq Stockholm
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Lifco AB (publ)'s moat claims, evidence, and risks.
View LIFCO-B analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 58 / 100 for Lifco AB (publ)).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Lifco AB (publ) has 3 segments (51.2% in Systems Solutions).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Lifco AB (publ) has 8 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Lifco AB (publ)
Systems Solutions
Niche B2B systems solutions (contract manufacturing, environmental technology, infrastructure products, special products, transportation products)
Primarily Europe; global customers where applicable
B2B OEMs and industrial customers
Niche manufacturer and systems solution provider
51.2%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
Lifco AB (publ) strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Lifco AB (publ) segments
Full profile >Dental
Oligopoly
Demolition & Tools
Oligopoly
Systems Solutions
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.